JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes
Key Dates: August 15, 2014: Expressions of interest (EOI) release date October 10, 2014: EOI due date October 31, 2014: EOI decision notification December 10, 2014: Full application due date (for accepted EOIs) April 2015: Award notification May 2015: Earliest start date Purpose of Request JDRF is soliciting expressions of interest (EOI) for the discovery, development, pre-clinical or pilot clinical testing of novel antigen-specific therapeutic approaches designed to induce durable immunoregulation for human type 1 diabetes (T1D). JDRF is committed to translation of research findings toward...
Source: ScanGrants feed - September 10, 2014 Category: Research Authors: JDRF Source Type: funding
Request for Expressions of Interest: Exploratory Clinical Trials of Non-insulin Adjunct Therapies in Type 1 Diabetes
Expression of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Expressions of Interest (EOI) for clinical trials to evaluate non-insulin based adjunct therapies for improved glycemic and overall metabolic control of T1D. JDRF has an unprecedented opportunity to make progress in the clinical assessment of adjunctive therapies for T1D that move beyond an insulin-centric view of the disease. At present, several agents–mostly approved T2D therapies such as incretins, SGLT inhibitors, metform...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding
Request for Letters of Intent: Glucose Responsive Insulin Discovery and Validation
Letter of Interest Deadline: July 11, 2014 JDRF, the world’s leading non-profit organization with the mission to cure, treat and prevent type 1 diabetes (T1D), invites Letters of Intent (LOI) for the discovery and validation of novel glucose responsive insulin (GRI) drugs for better treatment of insulin-dependent diabetes mellitus (IDDM) and reducing the burden of daily management of the disease, particularly T1D. Proposals (supported by strong rationale and/or preliminary data) will be considered for a maximum budget of up to $500,000* per year for up to 3 years of funding (including 10% indirect ...
Source: ScanGrants feed - May 27, 2014 Category: Research Authors: JDRF Source Type: funding
Call for Nominations: Banting Medal for Scientific Achievement Award
Banting Medal for Scientific Achievement Award The Banting Medal for Scientific Achievement Award is the highest scientific award of the American Diabetes Association. Given in memory of Sir Frederick Banting, a medical scientist, doctor and Nobel laureate who is noted as one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually to honor highly meritorious career achievement in the field of diabetes research. Criteria for Selection: Nominee will have demonstrated significant, long-term contribution to the understanding of diabetes, its treatment and/or prevention. Publicat...
Source: ScanGrants feed - May 21, 2014 Category: Research Authors: American Diabetes Association Source Type: funding
Request for Proposals: Automated Insulin Delivery Initiative
LOI Submission Deadline: January 15, 2014 Over the past decade, advances in medical device technology have had significant impact on monitoring, management and treatment of type 1 diabetes (T1D). However, data from the T1D Exchange demonstrates that T1D is still not a safe or well-managed disease, despite using today’s tools. Thus, the goal of the Automated Insulin Delivery Initiative (AIDI) of The Leona M. and Harry B. Helmsley Charitable Trust (HCT) Type 1 Diabetes (T1D) Program is to accelerate the development and regulatory approval of automated insulin delivery systems to improve the management an...
Source: ScanGrants feed - December 31, 2013 Category: Research Authors: Leona M. and Harry B. Helmsley Charitable Trust Source Type: funding
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
Funding Opportunity Number: RFA-DK-13-028 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Mar 14, 2014Award Ceiling: Expected Number of Awards: Creation Date: Dec 04, 2013Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative t...
Source: Grants.gov - December 4, 2013 Category: Research Tags: Food and Nutrition Health Source Type: funding
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44)
Funding Opportunity RFA-DK-13-028 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2013 Category: Research Source Type: funding
Call for Nominations: American Diabetes Association 2014 Banting Medal for Scientific Achievement Award
Deadline: October 18, 2013 The Banting Medal for Scientific Achievement Award is the highest scientific award of the American Diabetes Association. Given in memory of Sir Frederick Banting, a medical scientist, doctor and Nobel laureate who is noted as one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually to honor highly meritorious career achievement in the field of diabetes research. Criteria for Selection: • Nominee will have demonstrated significant, long-term contribution to the understanding of diabetes, its treatment and/or prevention. • Public...
Source: ScanGrants feed - July 22, 2013 Category: Research Authors: American Diabetes Association Source Type: funding
Request for Proposals: Creative Computational Approaches to Accelerate Drug Discovery for the Treatment and Prevention of Dementia
Current methods of drug discovery have had limited success at predicting clinical efficacy of investigational therapies in patients with Alzheimer’s disease and other age-related dementias. Computational modeling, systems biology and pharmacology, and translational bioinformatics represent a tremendous yet relatively under-developed opportunity to accelerate and improve this process particularly for dementias. The Alzheimer’s Drug Discovery Foundation (ADDF) program on Aging & Alzheimer’s Disease Prevention is requesting proposals for innovative computational approaches to map disease a...
Source: ScanGrants feed - June 4, 2013 Category: Research Authors: Alzheimer’s Drug Discovery Foundation Source Type: funding
JDRF Requests Expressions of Interest for Studies Relevant to the Discovery and Development of Antigen Specific Therapies for Human Type 1 Diabetes
Key Dates: February 13, 2013: Expressions of interest (EOI) due date (EOIs must be submitted via the proposalCentral website: https://proposalcentral.altum.com) March 8, 2013: EOI decision notification April 15, 2013: Full application due date (for accepted EOIs) July 2013: Award notification Purpose of Request JDRF is soliciting expressions of interest (EOI) for the discovery, development, pre-clinical or pilot clinical testing of novel antigen-specific therapeutic approaches designed to induce durable immunoregulation for human type 1 diabetes (T1D). JDRF is committed to translation of re...
Source: ScanGrants feed - January 30, 2013 Category: Research Authors: JDRF Source Type: funding
